Ironwood Pharmaceuticals Ownership | Who Owns Ironwood Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Ironwood Pharmaceuticals Ownership Summary


Ironwood Pharmaceuticals is owned by 90.42% institutional investors, 2.66% insiders, and 6.92% retail investors. Blackrock is the largest institutional shareholder, holding 14.51% of IRWD shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.66% of its assets in Ironwood Pharmaceuticals shares.

IRWD Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockIronwood Pharmaceuticals90.42%2.66%6.92%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustrySpecialty & Generic Drug Manufacturers Stocks43.51%11.55%44.95%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock22.88M14.51%$149.16M
Vanguard group19.54M12.23%$86.56M
Armistice capital16.15M9.99%$11.58M
Sarissa capital management lp15.92M9.84%$11.42M
Blackrock funding, inc. /de12.02M7.43%$8.62M
State street9.24M5.86%$60.26M
Renaissance9.07M5.68%$40.16M
Acadian asset management6.55M4.05%$4.68M
Kynam capital management, lp5.47M3.38%$3.92M
Morgan stanley4.86M3.08%$31.69M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sarissa capital management lp15.92M7.40%$11.42M
Kynam capital management, lp5.47M0.42%$3.92M
Armistice capital16.15M0.20%$11.58M
Jacobs levy equity management4.36M0.12%$28.42M
Renaissance9.07M0.06%$40.16M
Inspire investing552.42K0.04%$396.20K
First dallas securities11.25K0.03%$73.35K
State of wyoming41.86K0.02%$185.43K
Artal group110.53K0.02%$720.67K
China universal asset management33.93K0.01%$150.32K

Top Buyers

HolderShares% AssetsChange
Acadian asset management6.55M0.01%3.90M
Marshall wace, llp3.99M0.00%3.44M
Armistice capital16.15M0.20%2.45M
Morgan stanley4.86M0.00%2.18M
Millennium management2.18M0.00%1.25M

Top Sellers

HolderShares% AssetsChange
Braidwell lp---6.62M
State street9.24M0.00%-4.67M
Brown capital management---2.58M
Vanguard group19.54M0.00%-2.50M
Pacer advisors---1.79M

New Positions

HolderShares% AssetsChangeValue
Federated hermes370.48K0.00%370.48K$1.64M
Norges bank252.29K0.00%252.29K$1.12M
Algert global122.58K0.00%122.58K$88.00K
Oversea-chinese banking35.02K0.00%35.02K$25.11K
Colony group34.55K0.00%34.55K$24.78K

Sold Out

HolderChange
Natixis-2.00
Sjs investment consulting-5.00
Jfs wealth advisors-10.00
Mendota financial group-11.00
Dinuzzo private wealth-15.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025153-24.26%146,234,9095.06%901.21%76-27.62%49-20.97%
Mar 31, 2025201-11.45%155,281,777-5.40%960.91%104-11.86%62-18.42%
Dec 31, 2024213-3.62%155,039,542-4.94%970.93%1104.76%71-7.79%
Sep 30, 2024220-4.76%163,072,766-4.90%1020.86%104-9.57%77-2.53%
Jun 30, 2024231-19.23%171,479,228-0.14%1080.92%115-22.30%79-3.66%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF9.06M5.66%-
Vanguard US Total Market Shares ETF4.18M2.59%-
Vanguard Total Stock Mkt Idx Inv4.10M2.52%-90.46K
iShares Russell 2000 ETF3.69M2.28%-70.25K
SPDR® S&P Biotech ETF2.51M1.57%-15.31K
Vanguard Strategic Equity Inv2.45M1.51%-
Vanguard Explorer Inv2.23M1.38%-
Schwab Fundamental U.S. Small CompanyETF2.14M1.32%-
Vanguard Small Cap Index1.74M1.09%1.41K
Vanguard Institutional Extnd Mkt Idx Tr1.55M0.95%-704.83K

Recent Insider Transactions


DateNameRoleActivityValue
Aug 11, 2025Gaskins Tammi L Chief Commercial OfficerSell$1.11K
Aug 11, 2025John Minardo Chief Legal OfficerSell$6.51K
Aug 11, 2025Martini Gregory S. Chief Financial OfficerSell$1.06K
Aug 11, 2025Silver Ronald Principal Accounting OfficerSell$2.39K
May 16, 2025MCCOURT Thomas A Chief Executive OfficerSell$7.74K

Insider Transactions Trends


DateBuySell
2025 Q3-4
2025 Q2-2
2025 Q1-5
2024 Q4-2
2024 Q3-2

IRWD Ownership FAQ


Who Owns Ironwood Pharmaceuticals?

Ironwood Pharmaceuticals shareholders are primarily institutional investors at 90.42%, followed by 2.66% insiders and 6.92% retail investors. The average institutional ownership in Ironwood Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 43.51%, which Ironwood Pharmaceuticals exceeds.

Who owns the most shares of Ironwood Pharmaceuticals?

Ironwood Pharmaceuticals’s largest shareholders are Blackrock (22.88M shares, 14.51%), Vanguard group (19.54M shares, 12.23%), and Armistice capital (16.15M shares, 9.99%). Together, they hold 36.73% of Ironwood Pharmaceuticals’s total shares outstanding.

Does Blackrock own Ironwood Pharmaceuticals?

Yes, BlackRock owns 14.51% of Ironwood Pharmaceuticals, totaling 22.88M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 149.16M$. In the last quarter, BlackRock decreased its holdings by -1.281M shares, a -5.30% change.

Who is Ironwood Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Sarissa capital management lp is Ironwood Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 7.40% of its assets in 15.92M Ironwood Pharmaceuticals shares, valued at 11.42M$.

Who is the top mutual fund holder of Ironwood Pharmaceuticals shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Ironwood Pharmaceuticals shares, with 5.66% of its total shares outstanding invested in 9.06M Ironwood Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools